Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor

被引：0
|
作者：
Wylie, Natasha S. [1 ]
Sokumbi, Olayemi [2 ]
Starr, Jason S. [1 ]
机构：
[1] Mayo Clin, Div Hematol & Med Oncol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Dermatol, Jacksonville, FL 32224 USA
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 12期
关键词：
D O I：
10.1001/jamaoncol.2021.5578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1891 / 1892
页数：2
相关论文
共 50 条
  • [21] The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA).
    Goyal, Lipika
    Lamarca, Angela
    Strickler, John H.
    Cecchini, Michael
    Ahn, Daniel H.
    Baiev, Islam
    Boileve, Alice
    Tazdait, Melodie
    Hannan, Lindsay Marie
    Jia, Jingquan
    Marble, Hetal Desai
    Barzi, Afsaneh
    Sahai, Vaibhav
    Lennerz, Jochen K.
    Kelley, Robin Kate
    Bekaii-Saab, Tanios S.
    Javle, Milind M.
    Uboha, Nataliya Volodymyrivna
    Harris, William P.
    Hollebecque, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Histopathology of acneiform eruptions in patients treated with epidermal growth factor receptor inhibitors
    Brodell, Lindsey A.
    Hepper, Donna
    Lind, Anne
    Gru, Alejandro A.
    Anadkat, Milan J.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2013, 40 (10) : 865 - 870
  • [23] Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
    Presta, M
    Dell'Era, P
    Mitola, S
    Moroni, E
    Ronca, R
    Rusnati, M
    CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (02) : 159 - 178
  • [24] Efficacy of TAS-120, an irreversible fibroblast growth factor receptor inhibitor (FGFRi), in patients with cholangiocarcinoma and FGFR pathway alterations previously treated with chemotherapy and other FGFRi's
    Tran, B.
    Meric-Bernstam, F.
    Arkenau, H-T.
    Bahleda, R.
    Kelley, R. K.
    Hierro, C.
    Ahn, D.
    Zhu, A.
    Javle, M.
    Winkler, R.
    He, H.
    Huang, J.
    Goyal, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] The interaction of fibroblast growth factor/fibroblast growth factor receptor and FGF inhibitors
    Fan, HK
    Zhou, H
    Li, W
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (03) : 338 - 341
  • [26] Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling
    Friesel, R
    Maciag, T
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 748 - 754
  • [27] Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half-Opened
    Rizvi, Sumera
    Gores, Gregory J.
    HEPATOLOGY, 2018, 68 (06) : 2428 - 2430
  • [28] Antiangiogenic Activity of Alofanib, an Allosteric Inhibitor of Fibroblast Growth Factor Receptor 2
    D. A. Khochenkov
    E. Sch. Solomko
    N. M. Peretolchina
    O. O. Ryabaya
    E. V. Stepanova
    Bulletin of Experimental Biology and Medicine, 2015, 160 : 84 - 87
  • [29] Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor
    Wu, Liangxing
    Zhang, Colin
    He, Chunhong
    Qian, Dingquan
    Lu, Liang
    Sun, Yaping
    Xu, Meizhong
    Zhuo, Jincong
    Liu, Phillip C. C.
    Klabe, Ronald
    Wynn, Richard
    Covington, Maryanne
    Gallagher, Karen
    Leffet, Lynn
    Bowman, Kevin
    Diamond, Sharon
    Koblish, Holly
    Zhang, Yue
    Soloviev, Maxim
    Hollis, Gregory
    Burn, Timothy C.
    Scherle, Peggy
    Yeleswaram, Swamy
    Huber, Reid
    Yao, Wenqing
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 10666 - 10679
  • [30] Serous Retinopathy Associated With Combination MEK and Fibroblast Growth Factor Receptor Inhibitor
    Day, H. Russell
    Finn, Avni P.
    JOURNAL OF VITREORETINAL DISEASES, 2023, 7 (04) : 352 - 355
12345